Eris Lifesciences Ltd.
Snapshot View

View in App

Prices View details >>

571.00 +2.50 ▲0.4%

24 March 2023, 04:01:00 PM
Volume: 1,033

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.eris.co.in
Market Cap 7,784.20 Cr.
Enterprise Value(EV) 7,930.13 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 29.20 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.56 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 163.23 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.50 Calculated using Price: 571.00
Dividend Yield 1.05 Period Ending 2022-03
No. of Shares Subscribed 13.60 Cr. 135,992,238 Shares
FaceValue 1
Company Profile
The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.44%
1 Week
+0.43%
1 Month
-10.82%
3 Month
-11.76%
6 Month
-17.66%
1 Year
-18.97%
2 Year
-1.75%
5 Year
-27.11%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 50.12 40.30 47.68 56.90 41.30 28.96 24.28 24.78 23.33
Return on Capital Employed (%) 68.93 49.25 54.56 62.56 35.76 26.54 25.44 27.60 25.29
Return on Assets (%) 32.09 28.59 36.17 43.89 27.31 20.02 20.33 22.62 21.27

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 177 266 300 567 861 1,151 1,296 1,576 1,908 2,027
Non Curr. Liab. 18 19 20 12 248 -66 -80 -109 -79 183
Curr. Liab. 71 65 69 129 294 377 220 235 283 360
Minority Int. 4 4 3 24 25 18 0 30
Equity & Liab. 270 354 392 732 1,428 1,481 1,437 1,703 2,113 2,600
Non Curr. Assets 115 191 169 463 1,061 827 902 1,167 1,402 1,984
Curr. Assets 155 163 222 270 367 653 535 536 711 615
Misc. Exp. not W/O
Total Assets 270 354 392 732 1,428 1,481 1,437 1,703 2,113 2,600

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 509 546 597 750 856 982 1,074 1,212 1,347 1,588
Other Income 4 3 3 25 26 32 16 9 26 18
Total Income 513 549 600 775 882 1,014 1,090 1,221 1,373 1,607
Total Expenditure -410 -424 -425 -480 -533 -637 -706 -781 -862 -1,074
PBIDT 103 125 175 294 349 377 384 439 511 533
Interest 0 0 0 -1 -11 -23 -2 -2 -4 -19
Depreciation -5 -16 -20 -23 -26 -36 -50 -43 -65 -100
Taxation -27 -20 -20 -24 -17 -26 -35 -39 -36 -21
Exceptional Items
PAT 71 89 135 247 295 291 297 355 406 393
Minority Interest 0 0 -1 0 -1 0 0 0 4
Share Associate
Other Related Items
Consolidated Net Profit 71 89 134 247 294 291 297 355 406 397
Adjusted EPS 5,130 6,466 9,679 18 21 21 22 26 30 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 38 90 90 131 200 235 223 271 375 378
Cash Fr. Inv. -36 -83 -92 -44 -184 -590 -5 123 -323 -320
Cash Fr. Finan. -3 -2 0 -84 -24 363 -221 -335 -82 -45
Net Change -1 5 -2 4 -8 8 -3 60 -30 14
Cash & Cash Eqvt 2 7 5 9 2 11 8 67 37 51

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 54.23 54.13 52.69 52.68 52.66 52.66 52.30 52.29 52.70
Public 45.77 45.87 47.31 47.32 47.34 47.34 47.70 47.71 47.30
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 24 Mar 2023
Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our earlier intimations dated 16th March 2023 for acquisition of nine cosmetic dermatology brands from Dr.Reddys Laboratories Ltd. and 21st March 2023 for updation of the deal completion date
Thu, 23 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
TRANSCRIPT OF CONFERENCE CALLSCHEDULED IN CONNECTION WITH THE ACQUISITION OF NINE DERMATOLOGY BRANDS FROM DR.REDDYS LABORATORIES LTD
Tue, 21 Mar 2023
Announcement under Regulation 30 (LODR)-Updates on Acquisition
UPDATE ON ACQUISITIONWe refer to the announcement made on 16th March 2023 pertaining to the acquisition of a part of the dermatology portfolio of Dr. Reddys Laboratories Ltd. by way of acquisition of 9 (Nine) trademarks along with their applicable line Extensions.It is hereby notified that based on the comfort derived from the information records documents provided by Dr. Reddys Laboratories Limited so far the completion has been advanced and is now targeted to happen on or about 24th March 2023 instead of the previously targeted date of 31st March 2023.

Technical Scans View Details >>

Fri, 24 Mar 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Eris Lifesciences Ltd.

What is Eris Lifesciences share price?
Can I buy Eris Lifesciences shares now?
What is the Dividend Yield of Eris Lifesciences?
What is the Market Cap of Eris Lifesciences?
What are the key metrics to analyse Eris Lifesciences?
What is the 52 Week High and Low of Eris Lifesciences?
What is the trend of Eris Lifesciences share price?